Chemical
(R)-(3-(3-Fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl dihydrogen phosphate
[(5R)-3-[3-fluoro-4-[6-(2-methyltetrazol-5-yl)pyridin-3-yl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl dihydrogen phosphate
CAS: 856867-55-5
Formula: C17H16FN6O6P
Specifications
Key details (from tblproducts)
| CAS | 856867-55-5 |
| Molecular formula | C17H16FN6O6P |
| Molecular weight | 450.3 |
| IUPAC | [(5R)-3-[3-fluoro-4-[6-(2-methyltetrazol-5-yl)pyridin-3-yl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl dihydrogen phosphate |
Supplier listings below are pulled from tblproductsupplier + tblsuppliers.
Suppliers
Suppliers offering this product
| Supplier | Country | Stock | Action |
|---|---|---|---|
| TLC Pharmaceutical Standards Ltd | Canada | In Stock | View |
| Matrix Scientific | United States | In Stock | View |
| Toronto Research Chemicals | Canada | In Stock | View |
| archie chem | United Kingdom | In Stock | View |
| Arham Expochem | INDIA | In Stock | View |
| Beijing Yibai Biotech Ltd. | CHINA | In Stock | View |
| BOC Sciences | United States | — | View |
| Chengdu Astatech Chemical Technology Co., Ltd | CHINA | In Stock | View |
| Chengdu Miracle Pharmaceutical | CHINA | In Stock | View |
| Daddy Pharma Services | UNITED KINGDOM | — | View |
| DC chemicals | CHINA | In Stock | View |
| Enkepharma | CHINA | In Stock | View |
| Leapchem | India | In Stock | View |
| LKT Labs | United States | In Stock | View |
| Molcan Corporation | Canada | In Stock | View |
| Parchem | United States | In Stock | View |
| RXN CHEMICALS PVT. LTD. | INDIA | In Stock | View |
| SAURAV CHEMICALS LIMITED | INDIA | In Stock | View |
| Shandong Shining Pharm Co.,Ltd. | CHINA | In Stock | View |
| Shandong Zhonghan Pharmaceutical | CHINA | In Stock | View |
| Suzhou Jingye Medicine & Chemical Co., Ltd | CHINA | — | View |
| Aaron Chemicals LLC | United States | In Stock | View |
| Shanghai Desano Pharmaceutical Group Co., LTD | China | In Stock | View |
| SHANGHAI ICHEMICAL CO., LTD. | CHINA | In Stock | View |